These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 4926920)
21. [The trial of intravenous L-DOPA in patients with Parkinson's disease]. Nardini M; Fieschi C; Agnoli A; Arcioli I; Zanette E Riv Neurol; 1970; 40(2):75-85. PubMed ID: 5429003 [No Abstract] [Full Text] [Related]
22. [Treatment with L-dopa in Parkinsonian syndromes]. De Renzi E; Pieczuro A Sist Nerv; 1970; 22(1):1-11. PubMed ID: 5502951 [No Abstract] [Full Text] [Related]
23. [Toulouse-Piéron test in patients with Parkinsonism treated with L-dopa]. Megna GF; Puca FM; Leggiadro N; Micalizzi V; Pigneri MT Acta Neurol (Napoli); 1973; 28(2):213-22. PubMed ID: 4575429 [No Abstract] [Full Text] [Related]
24. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes]. Kluzer G; Lampo B Minerva Med; 1971 Oct; 62(82):4013-4. PubMed ID: 5125067 [No Abstract] [Full Text] [Related]
25. [Current status of therapy of parkinsonism]. Walton JN Recenti Prog Med; 1971 Sep; 51(3):274-88. PubMed ID: 5171957 [No Abstract] [Full Text] [Related]
26. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes and their implications for rehabilitation]. Raspa EG; Paciaroni E; Saccomanno G Minerva Med; 1971 Oct; 62(82):4031-5. PubMed ID: 5125073 [No Abstract] [Full Text] [Related]
35. [L-Dopa-Propranolol association and parkinsonian trembling]. Kissel P; Tridon P; Masingue M; Andre JM Nouv Presse Med; 1972 Jul; 1(29):1943. PubMed ID: 5053603 [No Abstract] [Full Text] [Related]
36. [Treatment of parkinsonian akinesia]. Travenets IA Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(5):703-6. PubMed ID: 5998829 [No Abstract] [Full Text] [Related]
37. [Current therapeutic problems of the parkinson syndrome]. Völler GW; Kapp W Med Welt; 1971 Aug; 33():1280-2. PubMed ID: 5566844 [No Abstract] [Full Text] [Related]
38. [Our first observations on Parkinson's disease or parkinsonian syndromes treated with L-dopa]. Boudouresques J; Khalil R; Vigouroux RA; Gosset A; Daniel F; Dufour H Mars Med; 1971; 108(2):85-9. PubMed ID: 5548385 [No Abstract] [Full Text] [Related]
39. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa]. Ambrosetto C; Martinelli P Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069 [No Abstract] [Full Text] [Related]
40. Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease. Hauser RA; Olanow CW Mov Disord; 1993 Oct; 8(4):512-4. PubMed ID: 8232363 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]